Nanotechnology has been more prevalent in our daily lives in recent years. Through an integrated approach, this ground-breaking technology has been implemented in a variety of industries. Nanomedicine is the application of nanotechnology for medical reasons, and it is described as the use of nanoparticles for disease diagnosis, monitoring, control, prevention, and therapy. Nanomedicine is the use of nanotechnology to accomplish healthcare innovation. Furthermore, the nanometric scale is also the scale of many biological mechanisms in the human body, allowing nanoparticles and nanomaterials to potentially cross natural barriers to reach new delivery sites and interact with DNA or small proteins at various levels, whether in blood or within organs, tissues, or cells. Hundreds of nanomedicine products are currently in clinical trials, spanning all major diseases such as cardiovascular, neurological, musculoskeletal, and inflammatory diseases. Nanomedicine is an enabling technology in all fields of healthcare, with over 80 marketed products ranging from nano-delivery and pharmaceuticals to medical imaging, diagnostics, and biomaterials.
Nanosensors are sensitive materials that transmit chemical, physical, and biological data regarding nanoparticles and recognition molecules. Nanosensors operate at the "Nano" level. The term "nano" refers to a measuring unit of approximately 109 meters. A nanosensor is a device that can transmit data and information about the behaviour and features of nanoscale particles to a macroscopic level. Nanosensors can be used to detect chemical or mechanical information on the nanoscale, such as the presence of chemical species and nanoparticles, or to monitor physical factors like temperature. The construction and application of nano sensors can be used to classify them.
Important Alert:
X
Title : Current and future of red and black phosphorus nanomaterials
Hai Feng Ji, Drexel University, United States
Title : Making a nano bandaIdâ„¢: The merging of nanotechnology and artificial intelligence (AI) for improved medicin
Thomas J Webster, Hebei University of Technology, United States
Title : Current status of scaled-up synthesis/purification and characterization of a potentially translatabletantalum oxide nanoparticle intravenous CT contrast agent
Peter J Bonitatibus, RPI, United States
Title : Logistic-modified mathematical model for tumor growth treated with nanosized cargo delivery system
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Artificial Intelligence (AI) in biomedical engineering
Hossein Hosseinkhani, Innovation Center for Advanced Technology, Matrix, Inc., United States
Title : Nanotechnology in nuclear reactors: Innovations in fusion and fission power generation
Bahman Zohuri, Galaxy Advanced Engineering, Mexico
Title : Atomistic simulation of chemical ordering phenomena in nanostructured intermetallics
Rafal Kozubski, Jagiellonian University in Krakow, Poland
Title : Highlighting recent advancements in electromagnetic field subwavelength tailoring using nanoparticle resonant light scattering and related topics
Michael I Tribelsky, Moscow State University, Russian Federation
Title : Azodye photoaligned nanolayers for liquid crystal: New trends
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Circumventing challenges in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University-Clayton Campus, Australia